Lux Industries Limited (LUXIND)
Investor Presentation
AI summary
- Q1 FY27 consolidated revenue 609 Cr, +1% YoY; EBITDA margin ~9.4% in Vertical A
- Vertical A: 8% revenue growth, 10% volume growth, EBITDA Rs.28 Cr (+45%)
- Vertical B: revenue Rs.249 Cr (-5.2%), 50% volume growth in Lux Venus Rainwear, exports +10%
- Vertical C: revenue Rs.69 Cr (-5.9%), EBITDA Rs.5.15 Cr (-5.7%), PBT Rs.3.84 Cr (-13.9%)
- New production facility expansion at Dankuni with Rs.600 Cr capex
- Strategic partnership with Reebok for innerwear and thermal wear in India
- Strong brand investments (~7% of revenue), premiumization focus, and multi-channel expansion
- Sustainability initiatives include 100% natural fiber products and increased solar power capacity
- Management team strengthened with experienced leadership and new brand ambassadors
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 LUXIND — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add LUXIND to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Lux Industries Limited
Important.
The summary above is generated automatically from Lux Industries Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.